(PDF) Pdb38 - Budget Impact Analysis of Benaglutide

Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.744

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Budget Impact Analysis of the Introduction of Saxagliptin/Metformin Extended-Release (Xr) in the Treatment of Type-2 Diabetes in Chile

Value in Health

Occupational Health

English

Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective

Value in Health

Occupational Health

English

Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis

Value in Health

Occupational Health

English

Budget Impact Analysis of Adding Dapaglifozin to the Therapy of Diabetes Mellitus Type 2 in Bulgaria

Value in Health

Occupational Health

English

Budget Impact Analysis of Utilizing Canagliflozin (CANA) for the Treatment of Type 2 Diabetes Mellitus (T2DM) in an United States Health Plan

Value in Health

Occupational Health

English

Budget Impact Analysis of Vildagliptin Treating T2dm in China

Value in Health

Occupational Health

English

Impact of Type 2 Diabetes Mellitus on Recurrent Myocardial Infarction in China

Diabetes and Vascular Disease Research

Internal Medicine

Cardiovascular Medicine

English

Pdb37 - Budget Impact Analysis of the Adult Type 1 Diabetes Mellitus National Clinical Guideline in Ireland

Value in Health

Occupational Health

English

Impact of Insulin Treatment in Diabetic Macular Edema Therapy in Type 2 Diabetes

Canadian Journal of Diabetes

Internal Medicine

English